HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BAY59

antineoplastic; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Diterpenes: 1470
      - Taxoids: 2650
        BAY59: 1
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclodecanes
        Taxoids: 2650
        BAY59: 1

Experts

1.	Bernacki, R J: 1 article (01/2004)
2.	Creaven, P J: 1 article (01/2004)
3.	Eckhardt, S G: 1 article (01/2004)
4.	Hamm, J: 1 article (01/2004)
5.	Holden, S: 1 article (01/2004)
6.	Kanter, P: 1 article (01/2004)
7.	Lathia, C: 1 article (01/2004)
8.	Ramnath, N: 1 article (01/2004)
9.	Schwartz, G: 1 article (01/2004)
10.	Vredenburg, M R: 1 article (01/2004)

Related Diseases

1.

Neoplasms (Cancer)

01/01/2004 - "Initially, 15 patients with previously treated (median of 4 prior chemotherapy regimens) refractory cancers, but with normal marrow, hepatic and renal function were treated with BAY59 at doses of 15, 30, 50, 75 and 100 mg/m2 using a standard dose escalation design. "
01/01/2004 - "To determine the maximum tolerated dose (MTD), the dose limiting toxicities (DLT) and the pharmacokinetics of BAY59, a novel taxane given as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory solid tumors. "

Related Drugs and Biologics

1.	taxane

Related Therapies and Procedures

1.	Intravenous Infusions
2.	Drug Therapy (Chemotherapy)